Cell-free circulating DNA integrity is an independent predictor of impending breast cancer recurrence
Open Access
- 24 April 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (33) , 54537-54547
Abstract
Cell-free circulating DNA integrity is an independent predictor of impending breast cancer recurrence Cell-free circulating DNA integrity is an independent predictor of impending breast cancer recurrenceKeywords
This publication has 52 references indexed in Scilit:
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast CancerNew England Journal of Medicine, 2013
- Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trialsThe Lancet, 2011
- Circulating tumour markers can define patients with normal colons, benign polyps, and cancersBritish Journal of Cancer, 2011
- A multimarker QPCR-based platform for the detection of circulating tumour cells in patients with early-stage breast cancerBritish Journal of Cancer, 2011
- Breast cancer subtypes and outcome after local and regional relapseAnnals of Oncology, 2011
- Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node MetastasisJAMA, 2011
- Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancerBreast Cancer Research, 2010
- Breast Cancer Prognosis and Occult Lymph Node Metastases, Isolated Tumor Cells, and MicrometastasesJNCI: Journal of the National Cancer Institute, 2010
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerNew England Journal of Medicine, 2004
- Initial sequencing and analysis of the human genomeNature, 2001